Does the media refer more to KIDS or RCEL?

In the previous week, OrthoPediatrics had 1 more articles in the media than Avita Medical. MarketBeat recorded 2 mentions for OrthoPediatrics and 1 mentions for Avita Medical. OrthoPediatrics' average media sentiment score of 0.00 equaled Avita Medical'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OrthoPediatrics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Avita Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to CLPT or RCEL?

In the previous week, ClearPoint Neuro had 3 more articles in the media than Avita Medical. MarketBeat recorded 4 mentions for ClearPoint Neuro and 1 mentions for Avita Medical. ClearPoint Neuro's average media sentiment score of 0.86 beat Avita Medical's score of 0.00 indicating that ClearPoint Neuro is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ClearPoint Neuro 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Avita Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor RCEL or SI?

In the previous week, Shoulder Innovations had 2 more articles in the media than Avita Medical. MarketBeat recorded 3 mentions for Shoulder Innovations and 1 mentions for Avita Medical. Avita Medical's average media sentiment score of 0.00 beat Shoulder Innovations' score of -0.71 indicating that Avita Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avita Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Shoulder Innovations 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative

Is RCEL or CV more profitable?

Avita Medical has a net margin of -62.67% compared to CapsoVision's net margin of -198.87%. Company Net Margins Return on Equity Return on Assets Avita Medical -62.67% N/A -78.92% CapsoVision -198.87% N/A -136.03%

Avita Medical (RCEL) Competitors

$4.01 0.00 (0.00%)

Closing price 06/18/2026 04:00 PM Eastern

Extended Trading

$4.03 +0.02 (+0.37%)

As of 06/18/2026 07:03 PM Eastern

Compare

RCEL vs. KIDS, DCTH, CLPT, SI, and CV

Should you buy Avita Medical stock or one of its competitors? MarketBeat compares Avita Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Avita Medical include OrthoPediatrics (KIDS), Delcath Systems (DCTH), ClearPoint Neuro (CLPT), Shoulder Innovations (SI), and CapsoVision (CV). These companies are all part of the "medical equipment" industry.

How does Avita Medical compare to OrthoPediatrics?

OrthoPediatrics (NASDAQ:KIDS) and Avita Medical (NASDAQ:RCEL) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings.

In the previous week, OrthoPediatrics had 1 more articles in the media than Avita Medical. MarketBeat recorded 2 mentions for OrthoPediatrics and 1 mentions for Avita Medical. OrthoPediatrics' average media sentiment score of 0.00 equaled Avita Medical'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OrthoPediatrics	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Avita Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

OrthoPediatrics presently has a consensus target price of $24.44, indicating a potential upside of 29.54%. Avita Medical has a consensus target price of $7.25, indicating a potential upside of 80.80%. Given Avita Medical's higher possible upside, analysts plainly believe Avita Medical is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

OrthoPediatrics has a net margin of -16.31% compared to Avita Medical's net margin of -62.67%. Avita Medical's return on equity of 0.00% beat OrthoPediatrics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OrthoPediatrics	-16.31%	-7.01%	-4.86%
Avita Medical	-62.67%	N/A	-78.92%

OrthoPediatrics has a beta of 1.03, meaning that its share price is 3% more volatile than the broader market. Comparatively, Avita Medical has a beta of 1.87, meaning that its share price is 87% more volatile than the broader market.

OrthoPediatrics has higher revenue and earnings than Avita Medical. OrthoPediatrics is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OrthoPediatrics	$236.35M	2.05	-$39.65M	-$1.68	N/A
Avita Medical	$71.61M	1.72	-$48.59M	-$1.57	N/A

69.1% of OrthoPediatrics shares are owned by institutional investors. Comparatively, 27.7% of Avita Medical shares are owned by institutional investors. 32.7% of OrthoPediatrics shares are owned by insiders. Comparatively, 2.8% of Avita Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

OrthoPediatrics beats Avita Medical on 10 of the 15 factors compared between the two stocks.

How does Avita Medical compare to Delcath Systems?

Delcath Systems (NASDAQ:DCTH) and Avita Medical (NASDAQ:RCEL) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, media sentiment, risk, dividends, analyst recommendations, profitability and earnings.

Delcath Systems has higher revenue and earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Delcath Systems	$85.23M	4.73	$2.70M	$0.01	1,169.00
Avita Medical	$71.61M	1.72	-$48.59M	-$1.57	N/A

Delcath Systems has a net margin of 0.62% compared to Avita Medical's net margin of -62.67%. Delcath Systems' return on equity of 0.51% beat Avita Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Delcath Systems	0.62%	0.51%	0.46%
Avita Medical	-62.67%	N/A	-78.92%

61.1% of Delcath Systems shares are held by institutional investors. Comparatively, 27.7% of Avita Medical shares are held by institutional investors. 19.4% of Delcath Systems shares are held by company insiders. Comparatively, 2.8% of Avita Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Delcath Systems presently has a consensus target price of $22.50, suggesting a potential upside of 92.47%. Avita Medical has a consensus target price of $7.25, suggesting a potential upside of 80.80%. Given Delcath Systems' stronger consensus rating and higher possible upside, research analysts plainly believe Delcath Systems is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Delcath Systems	2 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.43
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, Avita Medical had 1 more articles in the media than Delcath Systems. MarketBeat recorded 1 mentions for Avita Medical and 0 mentions for Delcath Systems. Delcath Systems' average media sentiment score of 0.00 equaled Avita Medical'saverage media sentiment score.

Company	Overall Sentiment
Delcath Systems	Neutral
Avita Medical	Neutral

Delcath Systems has a beta of 0.54, meaning that its stock price is 46% less volatile than the broader market. Comparatively, Avita Medical has a beta of 1.87, meaning that its stock price is 87% more volatile than the broader market.

Summary

Delcath Systems beats Avita Medical on 13 of the 15 factors compared between the two stocks.

How does Avita Medical compare to ClearPoint Neuro?

ClearPoint Neuro (NASDAQ:CLPT) and Avita Medical (NASDAQ:RCEL) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, media sentiment, earnings, dividends and profitability.

In the previous week, ClearPoint Neuro had 3 more articles in the media than Avita Medical. MarketBeat recorded 4 mentions for ClearPoint Neuro and 1 mentions for Avita Medical. ClearPoint Neuro's average media sentiment score of 0.86 beat Avita Medical's score of 0.00 indicating that ClearPoint Neuro is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ClearPoint Neuro	1 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Avita Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

ClearPoint Neuro has higher earnings, but lower revenue than Avita Medical. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ClearPoint Neuro	$36.97M	14.41	-$25.54M	-$1.01	N/A
Avita Medical	$71.61M	1.72	-$48.59M	-$1.57	N/A

ClearPoint Neuro has a beta of 1.31, indicating that its share price is 31% more volatile than the broader market. Comparatively, Avita Medical has a beta of 1.87, indicating that its share price is 87% more volatile than the broader market.

30.1% of ClearPoint Neuro shares are held by institutional investors. Comparatively, 27.7% of Avita Medical shares are held by institutional investors. 6.9% of ClearPoint Neuro shares are held by insiders. Comparatively, 2.8% of Avita Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Avita Medical has a net margin of -62.67% compared to ClearPoint Neuro's net margin of -71.57%. Avita Medical's return on equity of 0.00% beat ClearPoint Neuro's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ClearPoint Neuro	-71.57%	-140.96%	-36.98%
Avita Medical	-62.67%	N/A	-78.92%

ClearPoint Neuro presently has a consensus target price of $23.00, suggesting a potential upside of 29.43%. Avita Medical has a consensus target price of $7.25, suggesting a potential upside of 80.80%. Given Avita Medical's higher probable upside, analysts clearly believe Avita Medical is more favorable than ClearPoint Neuro.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ClearPoint Neuro	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

ClearPoint Neuro beats Avita Medical on 8 of the 15 factors compared between the two stocks.

How does Avita Medical compare to Shoulder Innovations?

Avita Medical (NASDAQ:RCEL) and Shoulder Innovations (NYSE:SI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations, media sentiment and risk.

In the previous week, Shoulder Innovations had 2 more articles in the media than Avita Medical. MarketBeat recorded 3 mentions for Shoulder Innovations and 1 mentions for Avita Medical. Avita Medical's average media sentiment score of 0.00 beat Shoulder Innovations' score of -0.71 indicating that Avita Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avita Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Shoulder Innovations	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative

27.7% of Avita Medical shares are owned by institutional investors. 2.8% of Avita Medical shares are owned by insiders. Comparatively, 29.0% of Shoulder Innovations shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Avita Medical currently has a consensus target price of $7.25, indicating a potential upside of 80.80%. Shoulder Innovations has a consensus target price of $21.00, indicating a potential upside of 12.66%. Given Avita Medical's higher probable upside, equities research analysts clearly believe Avita Medical is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Shoulder Innovations has lower revenue, but higher earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avita Medical	$71.61M	1.72	-$48.59M	-$1.57	N/A
Shoulder Innovations	$47.32M	8.17	-$40.36M	-$166.96	N/A

Avita Medical has a net margin of -62.67% compared to Shoulder Innovations' net margin of -81.78%. Avita Medical's return on equity of 0.00% beat Shoulder Innovations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avita Medical	-62.67%	N/A	-78.92%
Shoulder Innovations	-81.78%	-35.11%	-20.58%

Summary

Shoulder Innovations beats Avita Medical on 8 of the 15 factors compared between the two stocks.

How does Avita Medical compare to CapsoVision?

Avita Medical (NASDAQ:RCEL) and CapsoVision (NASDAQ:CV) are both small-cap medical equipment companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends.

27.7% of Avita Medical shares are owned by institutional investors. 2.8% of Avita Medical shares are owned by insiders. Comparatively, 2.3% of CapsoVision shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

CapsoVision has lower revenue, but higher earnings than Avita Medical. CapsoVision is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avita Medical	$71.61M	1.72	-$48.59M	-$1.57	N/A
CapsoVision	$13.55M	24.37	-$25.32M	-$2.34	N/A

Avita Medical has a net margin of -62.67% compared to CapsoVision's net margin of -198.87%.

Company	Net Margins	Return on Equity	Return on Assets
Avita Medical	-62.67%	N/A	-78.92%
CapsoVision	-198.87%	N/A	-136.03%

Avita Medical presently has a consensus price target of $7.25, suggesting a potential upside of 80.80%. CapsoVision has a consensus price target of $8.50, suggesting a potential upside of 28.59%. Given Avita Medical's higher probable upside, research analysts plainly believe Avita Medical is more favorable than CapsoVision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
CapsoVision	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

In the previous week, Avita Medical had 1 more articles in the media than CapsoVision. MarketBeat recorded 1 mentions for Avita Medical and 0 mentions for CapsoVision. Avita Medical's average media sentiment score of 0.00 equaled CapsoVision'saverage media sentiment score.

Company	Overall Sentiment
Avita Medical	Neutral
CapsoVision	Neutral

Summary

Avita Medical beats CapsoVision on 10 of the 14 factors compared between the two stocks.

Get Avita Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RCEL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RCEL vs. The Competition

Export

Metric	Avita Medical	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$123.42M	$2.98B	$6.42B	$12.59B
Dividend Yield	N/A	1.78%	2.68%	5.81%
P/E Ratio	-2.55	18.67	24.78	24.44
Price / Sales	1.72	455.44	554.00	122.27
Price / Cash	N/A	56.42	45.07	55.09
Price / Book	-7.29	4.04	10.80	6.58
Net Income	-$48.59M	$75.79M	$3.57B	$337.17M
7 Day Performance	2.56%	0.38%	0.72%	0.83%
1 Month Performance	-10.49%	-0.14%	0.41%	2.25%
1 Year Performance	-22.44%	26.02%	29.34%	36.14%

Avita Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RCEL Avita Medical	3.0904 of 5 stars	$4.01 flat	$7.25 +80.8%	-22.4%	$123.42M	$71.61M	N/A	130	News Coverage Positive News
KIDS OrthoPediatrics	2.3061 of 5 stars	$18.49 +3.7%	$24.44 +32.2%	-7.0%	$472.41M	$236.35M	N/A	200	Positive News
DCTH Delcath Systems	2.2875 of 5 stars	$11.90 +0.9%	$22.50 +89.1%	-15.6%	$410.62M	$85.23M	1,189.50	60	Gap Up
CLPT ClearPoint Neuro	2.708 of 5 stars	$13.60 +0.6%	$18.00 +32.3%	+57.8%	$407.89M	$36.97M	N/A	110	News Coverage Positive News Analyst Forecast Options Volume
SI Shoulder Innovations	2.4993 of 5 stars	$18.64 +2.9%	$21.00 +12.7%	N/A	$386.57M	$47.32M	N/A	61	Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RCEL) was last updated on 6/21/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Avita Medical (RCEL) Competitors

RCEL vs. KIDS, DCTH, CLPT, SI, and CV

How does Avita Medical compare to OrthoPediatrics?

Summary

How does Avita Medical compare to Delcath Systems?

Summary

How does Avita Medical compare to ClearPoint Neuro?

Summary

How does Avita Medical compare to Shoulder Innovations?

Summary

How does Avita Medical compare to CapsoVision?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RCEL vs. The Competition

Avita Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Avita Medical (RCEL) Competitors

RCEL vs. KIDS, DCTH, CLPT, SI, and CV

How does Avita Medical compare to OrthoPediatrics?

Does the media refer more to KIDS or RCEL?

Do analysts prefer KIDS or RCEL?

Is KIDS or RCEL more profitable?

Which has more risk and volatility, KIDS or RCEL?

Which has higher valuation & earnings, KIDS or RCEL?

Do insiders and institutionals hold more shares of KIDS or RCEL?

Summary

How does Avita Medical compare to Delcath Systems?

Which has better earnings & valuation, DCTH or RCEL?

Is DCTH or RCEL more profitable?

Do institutionals and insiders hold more shares of DCTH or RCEL?

Do analysts prefer DCTH or RCEL?

Does the media refer more to DCTH or RCEL?

Which has more volatility & risk, DCTH or RCEL?

Summary

How does Avita Medical compare to ClearPoint Neuro?

Does the media refer more to CLPT or RCEL?

Which has better valuation & earnings, CLPT or RCEL?

Which has more volatility & risk, CLPT or RCEL?

Do insiders & institutionals believe in CLPT or RCEL?

Is CLPT or RCEL more profitable?

Do analysts recommend CLPT or RCEL?

Summary

How does Avita Medical compare to Shoulder Innovations?

Does the media favor RCEL or SI?

Do institutionals and insiders have more ownership in RCEL or SI?

Do analysts recommend RCEL or SI?

Which has better valuation and earnings, RCEL or SI?

Is RCEL or SI more profitable?

Summary

How does Avita Medical compare to CapsoVision?

Do institutionals & insiders hold more shares of RCEL or CV?

Which has preferable earnings & valuation, RCEL or CV?

Is RCEL or CV more profitable?

Do analysts prefer RCEL or CV?

Does the media favor RCEL or CV?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RCEL vs. The Competition

Avita Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools